Guideline Summary for Diagnosis and Management of Tuberculous Pericardial Effusion
Diagnostic Criteria
- Definite diagnosis requires demonstration of Mycobacterium tuberculosis in pericardial fluid or tissue by direct culture or Xpert MTB/RIF PCR. 1
- Probable diagnosis is established when tuberculosis is proven elsewhere in a patient with unexplained pericarditis, together with a lymphocytic pericardial exudate and elevated biomarkers or a favorable response to anti‑tuberculosis therapy in endemic areas. 1
Clinical Assessment
- A pericardial clinical score ≥ 6 (fever 1, night sweats 1, weight loss 2, globulin > 40 g/L 3, peripheral leukocytes < 10 × 10⁹/L 3) is highly suggestive of tuberculous pericarditis in endemic regions. 1
Imaging
- Chest radiograph shows pulmonary tuberculosis changes in ~30 % of cases and cardiac enlargement with a cardiothoracic ratio > 0.55 in all patients. 1
- Echocardiography is essential to confirm pericardial effusion and to assess for tamponade. 5
- CT/MRI should evaluate pericardial thickness > 3 mm and mediastinal lymphadenopathy > 10 mm with hypodense centers; mediastinal lymphadenopathy is present in 100 % of tuberculous cases and helps differentiate from viral/idiopathic effusions. 4
Microbiological Sampling
- Sputum, gastric aspirate, and urine should be cultured for M. tuberculosis in all patients with suspected tuberculous pericarditis. 4
- Interferon‑γ release assays (e.g., QuantiFERON, ELISpot) performed on blood are recommended. 6
- Tuberculin skin testing is not useful in adults, irrespective of background TB prevalence. 4
Pericardiocentesis
- Therapeutic pericardiocentesis is absolutely indicated for cardiac tamponade. 4
- Diagnostic pericardiocentesis should be considered in every patient with suspected tuberculous pericarditis. 8
Pericardial Fluid Analysis
| Test | Diagnostic Performance (cut‑off) | Evidence |
|---|---|---|
| Unstimulated interferon‑γ (uIFN‑γ) | Sensitivity 92‑98 %, Specificity 100 % at ≥ 50 pg/mL | [1] |
| Adenosine deaminase (ADA) | Sensitivity 87 %, Specificity 89 % at ≥ 40 U/L | [9] |
| Direct mycobacterial culture | Standard reference; positivity confirms TB | [3] |
| Xpert MTB/RIF PCR | Rapid nucleic‑acid detection; complements culture | [3] |
| Fluid cell count (lymphocytic exudate) | Strongly favors tuberculous etiology | [4] |
| Biochemical tests (protein, LDH) | Distinguish exudate from transudate | [3] |
Pericardial Biopsy
- Therapeutic biopsy is performed during surgical drainage for recurrent tamponade after pericardiocentesis. 4
- Diagnostic biopsy is not required before starting empiric therapy in endemic areas, but is recommended in non‑endemic areas when illness exceeds 3 weeks without a definitive diagnosis from other tests. 4
Empiric Anti‑Tuberculosis Therapy
- In endemic areas, empiric anti‑tuberculosis chemotherapy is recommended for exudative pericardial effusion after excluding malignancy, uremia, trauma, purulent pericarditis, and autoimmune disease. 8
- In non‑endemic areas, empiric therapy is not recommended when systematic investigations fail to identify a cause. 8